Temasek Helps Lead Series C Round in Arterys
Posted on 06/01/2020
On May 29, 2020, Arterys, Inc. is a global medical imaging platform. The company received its seventh USA FDA clearance. Arterys raised US$ 28 million in a Series C funding round led by an investor group by Benslie Investment Group and Singapore’s Temasek Holdings, with participation by Fosun, Revelation Partners, Emergent Medical Partners, and Varian Medical Systems. Seeking to transform radiology, Arterys said it will deploy this new round of financing to broaden the Arterys ecosystem.
In addition, Arterys has appointed John Axerio-Cilies, co-founder, as the acting CEO.
Benslie International Ltd is a Digital Health Investment vehicle of EMC2 Fund Ltd. It is an investment company founded by the Weinstein family.
